FindTrial
Sign In

To study the efficacy of tuvarakadi cream in the managment of eczema in children

A clinical study to assess the efficacy of tuvarakadi cream in the managment of charmadala in the age group of 6 months to 2 year childrem with special reference to atopic dermatitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085361
Enrollment
30
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of Vataj Charmadala. Infants and toddlers between the Age group 6 months to 2 years. Patients irrespective of sex, religion and socioeconomical status. Patient of the parent who will give written consent will be included.

Exclusion criteria

Exclusion criteria: Charmadala associated with sphota. Patient with associated skin infections such as herpes simplex, herpes zoster, scabies, impetigo or lichen simplex chronicus and congenital syphilis. Children having any other associated illness such as acute exacerbation of asthma or hey fever. Children admitted in NICU and PICU. Children receiving phototherapy. Patient with more than 60 % body surface involvement. Patient taking treatment from any other pathy for the same problem.

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Tuvarakadi cream in the management of charmadala in the age group of 6 months to 2 year old children in time span of 14 daysTimepoint: Treatment will be given for 14 days Tuvarakadi will be given to the patient for external application. Follow up and assessment will be done after7th day and 14th day. Final observation will be recorded after completion of treatment.—

Secondary

MeasureTime frame
To observe adverse effect & evaluate the safety of Tuvarakadi cream in the management of charmadala in the age group of 6 months to 2 year old children in the time span of 14 daysTimepoint: Study will be done using Ayurvedic Granthas & modern texts Preparation of drugs will be done according to standard procedure During treatment observation will be done on 7th day & 14th day. Later adverse effect will be studied—

Countries

India

Contacts

Public ContactDr Ramchandra Pandurang Babar

MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

ramchandrababar@gmail.com8275459236

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026